USA
Acceder
Cotización de Day One Biopharmaceuticals, Inc. (DAWN) hoy en tiempo real
Análisis técnico y gráfico histórico de Day One Biopharmaceuticals, Inc.
Análisis fundamental y estadísticas clave de Day One Biopharmaceuticals, Inc.
Ficha de Day One Biopharmaceuticals, Inc. (DAWN)
| Ticker | DAWN |
|---|---|
| ISIN | US23954D1090 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Day One Biopharmaceuticals, Inc.
Resumen financiero e información corporativa de Day One Biopharmaceuticals, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de Day One Biopharmaceuticals, Inc.
Márgenes de rentabilidad y Cash Flow de Day One Biopharmaceuticals, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de Day One Biopharmaceuticals, Inc.
Solvencia y deuda: Análisis del balance de Day One Biopharmaceuticals, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de Day One Biopharmaceuticals, Inc.
Invertir en Day One Biopharmaceuticals, Inc. en 2026: Preguntas frecuentes
¿Qué es Day One Biopharmaceuticals, Inc.?
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated pr...
¿En qué sector opera Day One Biopharmaceuticals, Inc.?
Day One Biopharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.
Otras acciones del sector Atención sanitaria